Ashutosh Pandey

Ashutosh Pandey

Active Director Director DIN 09242298
DIN 09242298 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Ashutosh Pandey

Data last updated:

Ashutosh Pandey is a Director at Luton Pharma Private Limited (since 2021). The company operates in Healthcare. Luton Pharma Private Limited reported revenue of ₹8.7 Lakh (FY 2022).

DIN 09242298
Primary Designation Director
Industry Healthcare
First Appointment 16 Jul 2021
Oldest Company Age 5 yrs
Largest company Luton Pharma Private Limited · ₹8.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Luton Pharma Private Limited U85100MH2021PTC364047
Director16 Jul 20212021₹8.7 Lakh (FY 2022)Active

Board colleagues of Ashutosh Pandey

Directorship timeline

Open interactive timeline →
Luton Pharma Private Limited
Premium access

Shareholding and investment profile for Ashutosh Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashutosh Pandey

Ashutosh Pandey currently holds 1 directorship: Luton Pharma Private Limited (Director, since 16 Jul 2021, revenue ₹8.7 Lakh (FY 2022)).

Ashutosh Pandey was first appointed on 16 Jul 2021 as Director at Luton Pharma Private Limited.

The current boards of Ashutosh Pandey's companies include Indu Manojkumar Singh (Luton Pharma Private Limited), Komal Shailendrra Patil (Luton Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available